🔴 MiniMed Group is trading 6.7% down in pre-market with no clear company-specific negative announcement

MiniMed Group is trading 6.7% down at $18.82 after no clear company-specific negative announcement was identified for August 21, 2026.

• The latest company news found was positive: on August 17, MiniMed announced its Flex insulin-pump system began shipping in the U.S. with Abbott’s Instinct sensor.
• The decline is occurring despite modestly higher futures, so broad market direction does not clearly explain the move.
• No new earnings release, downgrade, or regulatory action was found.